CI-1007

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C24H27N
Molecular Weight	329.4779
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C([C@@H]1CCC=C(C1)C2=CC=CC=C2)N3CCC(=CC3)C4=CC=CC=C4

InChI

InChIKey=XBGWTWPYCTZIIE-HXUWFJFHSA-N

InChI=1S/C24H27N/c1-3-9-21(10-4-1)23-14-16-25(17-15-23)19-20-8-7-13-24(18-20)22-11-5-2-6-12-22/h1-6,9-14,20H,7-8,15-19H2/t20-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C24H27N
Molecular Weight	329.4779
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Patents

Substance Class	Chemical Created by `admin` on `Sat Dec 16 11:13:34 GMT 2023` Edited by `admin` on `Sat Dec 16 11:13:34 GMT 2023`
Record UNII	Z5XDS9Z25L
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CI-1007

Code

English

PYRIDINE, 1,2,3,6-TETRAHYDRO-4-PHENYL-1-((3-PHENYL-3-CYCLOHEXEN-1-YL)METHYL)-, (R)-

Systematic Name

English

1,2,3,6-TETRAHYDRO-4-PHENYL-1-(((1R)-3-PHENYL-3-CYCLOHEXEN-1-YL)METHYL)PYRIDINE

Systematic Name

English

PD-143188

Code

English

Code System Code Type Description

PUBCHEM

127698

Created by admin on Sat Dec 16 11:13:34 GMT 2023 , Edited by admin on Sat Dec 16 11:13:34 GMT 2023

PRIMARY

CAS

150013-70-0

Created by admin on Sat Dec 16 11:13:34 GMT 2023 , Edited by admin on Sat Dec 16 11:13:34 GMT 2023

PRIMARY

EPA CompTox

DTXSID10933855

Created by admin on Sat Dec 16 11:13:34 GMT 2023 , Edited by admin on Sat Dec 16 11:13:34 GMT 2023

PRIMARY

FDA UNII

Z5XDS9Z25L

Created by admin on Sat Dec 16 11:13:34 GMT 2023 , Edited by admin on Sat Dec 16 11:13:34 GMT 2023

PRIMARY

Related Record Type Details


					8E4LAA4357

CYTOCHROME P450 2D6

METABOLIC ENZYME -> SUBSTRATE


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:


					G9XQ9S7T2F

D(3) DOPAMINE RECEPTOR

TARGET -> AGONIST

Interaction Type:

PARTIAL AGONIST


					19GBD6T9L7

D(2) DOPAMINE RECEPTOR

TARGET -> AGONIST

Interaction Type:

PARTIAL AGONIST

Related Record Type Details


					GVW83Z2EYV

PD-163637

METABOLITE -> PARENT


					4264O4MLU9

PD-155144

METABOLITE -> PARENT


					EDB3ZEZ46R

PD-147693

METABOLITE -> PARENT


					6O7M4WR1AP

PD-163639

METABOLITE -> PARENT

Related Record Type Details


					Z5XDS9Z25L

CI-1007

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Tmax	PHARMACOKINETIC				ORAL ADMINISTRATION